Turn Therapeutics reported net income of -$5.85M for the quarter ended Jun 2026. This income statement covers 8 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 26.69M | 26.85M | 27.26M | 28.02M | 29.45M | 29.45M | 29.79M | 29.79M |
| Operating items | ||||||||
| Research & DevelopmentR&D | 0.15M | 0.01M | 0.01M | 0.06M | 0.16M | 0.03M | 0.11M | 0.48M |
| Wages, Salaries and OtherWages | 0.07M | 0.30M | ||||||
| Selling, General & AdministrativeSG&A | 0.52M | 0.32M | 0.38M | 1.30M | 1.75M | 2.16M | 1.14M | 1.15M |
| Restructuring CostsRestructuring | 0.11M | 0.29M | ||||||
| Other Operating ExpensesOther Opex | -0.11M | -0.29M | ||||||
| Operating ExpensesOpex | 0.67M | 0.33M | 0.38M | 1.37M | 1.91M | 2.19M | 1.25M | 1.63M |
| Operating IncomeOp. Inc | -0.67M | -0.33M | -0.38M | -1.37M | -1.91M | -2.19M | -1.25M | -1.63M |
| EBIT | -0.67M | -0.33M | -0.38M | -1.37M | -1.91M | -2.19M | -1.25M | -1.63M |
| Non-operating items | ||||||||
| Non Operating Interest Expenses | 0.19M | 0.55M | ||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.05M | -0.24M |
| Other Non Operating IncomeOther Non Op Inc. | 0.05M | 0.12M | 0.00M | 2.40M | 0.70M | -3.34M | ||
| Non Operating IncomeNon Op. Inc. | 0.01M | 0.01M | 0.06M | 0.13M | 0.01M | 2.47M | 0.28M | -4.22M |
| Net income details | ||||||||
| EBT | -0.67M | -0.32M | -0.57M | -1.36M | -1.91M | -2.18M | -1.74M | -1.87M |
| Profit After TaxPAT | -0.67M | -0.32M | -0.33M | -1.24M | -1.90M | 0.27M | -0.97M | -5.85M |
| Income from Continuing OperationsIncome (Continuing) | -0.67M | -0.32M | -0.57M | -1.36M | -1.91M | -2.18M | -1.74M | -1.87M |
| Consolidated Net IncomeConsol Net Inc. | -0.67M | -0.32M | -0.57M | -1.36M | -1.91M | -2.18M | -1.74M | -1.87M |
| Income towards Parent CompanyParent Net Inc | -0.67M | -0.32M | -0.57M | -1.36M | -1.91M | -2.18M | -1.74M | -1.87M |
| Net Income towards Common StockholdersNet Income | -0.67M | -0.32M | -0.57M | -1.36M | -1.91M | -2.18M | -1.74M | -1.87M |
| Additional items | ||||||||
| EPS (Basic) | -0.03 | -0.01 | -0.02 | -0.05 | -0.07 | -0.08 | -0.06 | -0.06 |
| EPS (Diluted) | -0.03 | -0.01 | -0.02 | -0.05 | -0.07 | -0.08 | -0.06 | -0.06 |
| Shares Outstanding | 26.65M | 26.64M | 26.96M | 27.49M | 27.98M | 27.72M | 29.48M | 29.79M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 26.65M | 26.64M | 26.96M | 27.49M | 27.98M | 27.72M | 29.48M | 29.79M |
| EBITDA | -0.67M | -0.33M | -0.38M | -1.37M | -1.91M | -2.19M | -1.25M | -1.63M |
| Interest ExpensesInt Expense | 0.19M | 0.55M |